Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2022 07:00 ET | Source: Synlogic, Inc.

Synlogic Announces Data Presentations from Five Programs at the 2022 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference

CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
April 01, 2022 07:00 ET | Source: Synlogic, Inc.

Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for Inherited Metabolic Disorders 43rd Annual Meeting

CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
March 03, 2022 07:00 ET | Source: Synlogic, Inc.

Synlogic Announces Appointment of Michael Jensen as Chief Financial Officer

CAMBRIDGE, Mass., March 03, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
February 24, 2022 07:00 ET | Source: Synlogic, Inc.

Synlogic To Present at Upcoming Investor and Industry Conferences

CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
November 23, 2020 10:34 ET | Source: Augusta Fermentation QZ, LLC

Augusta Fermentation Qualified Opportunity Fund (QOF) Announces First Investment into the Manus Bio Qualified Opportunity Zone Business (QOZB).

WAYNE, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Augusta Fermentation Opportunity Zone Fund I, L.P. (AF I) today announced it has acquired an equity interest in Manus Bio’s QOZB which operates a...
November 28, 2017 14:33 ET | Source: Arzeda

Arzeda Officially Closes Series A with Total $15.2 Million to Revolutionize Chemical Production with Protein Design

SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design CompanyTM, today announced that it has officially closed its Series A funding round with a total investment of $15.2 million. ...
August 27, 2013 07:30 ET | Source: Lux Research

Embracing Open-Source Biotech: DNA Freeware May Out-Innovate Patented Genes

BOSTON, MA--(Marketwired - Aug 27, 2013) - With synthetic biology (synbio) rapidly gaining momentum, and a landmark U.S. Supreme Court judgment striking down an age-old biological patenting system,...